Moderna, Xpeng and Uber rise premarket; State Street falls

  • Stock Market News
Moderna, Xpeng and Uber rise premarket; State Street falls
Credit: © Reuters.

By Peter Nurse -- Stocks in focus in premarket trade on Monday, April 17th. Please refresh for updates.

  • Merck (NS: PROR ) (NYSE: MRK ) stock fell 0.1% after the drugs giant announced Sunday plans to acquire Prometheus Biosciences (NASDAQ: RXDX ), up 70%, for just short of $11 billion, building up its presence in immunology.

  • State Street (NYSE: STT ) stock fell 8.4% after the financial services company reported disappointing first-quarter results , with earnings and revenue both below expectations.

  • Moderna (NASDAQ: MRNA ) stock rose 2.5% after the company’s experimental mRNA cancer vaccine significantly cut the risk of death or recurrence of the most deadly skin cancer.

  • Xpeng (NYSE: XPEV ) stock rose 11% after the Chinese electric vehicle maker unveiled a new platform it developed in-house for making vehicles, which it said will reduce development and manufacturing costs.

  • Dell (NYSE: DELL ) stock fell 2.1% after JPMorgan downgraded its stance on the tech giant to ‘neutral’ from ‘overweight’, while HP (NYSE: HPQ ) stock rose 2.3% after the investment bank lifted it to ‘overweight’ from ‘neutral’.

  • Uber (NYSE: UBER ) stock rose 1.2% after Jefferies called the ride-sharing firm a top pick in a note, expecting long-term earnings growth to drive its shares around 50% higher.

  • M&T Bank (NYSE: MTB ) stock rose 3.1% after the lender beat expectations for first-quarter profit, as the Federal Reserve's rapid rate hikes to tame high inflation boosted its interest income.

  • Amneal Pharmaceuticals (NYSE: AMRX ) stock rose 8.8% after the pharma company reported strong first-quarter revenue growth and reaffirmed its 2023 guidance.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or


Related Articles